Kaempferol promotes the expression of miR-326 in colon cancer cells, which subsequently inhibits glycolysis by targeting pyruvate kinase M2 isoform (PKM2) 3′-UTR [231]. This evidence concerns the gene PKM and malignant colon neoplasm.